Amanda Leiter

2.2k total citations · 1 hit paper
46 papers, 1.4k citations indexed

About

Amanda Leiter is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Amanda Leiter has authored 46 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in Amanda Leiter's work include Cancer Immunotherapy and Biomarkers (14 papers), Lung Cancer Treatments and Mutations (5 papers) and Pituitary Gland Disorders and Treatments (4 papers). Amanda Leiter is often cited by papers focused on Cancer Immunotherapy and Biomarkers (14 papers), Lung Cancer Treatments and Mutations (5 papers) and Pituitary Gland Disorders and Treatments (4 papers). Amanda Leiter collaborates with scholars based in United States, Australia and Singapore. Amanda Leiter's co-authors include Juan P. Wisnivesky, Rajwanth Veluswamy, Matthew D. Galsky, H. Phillip Koeffler, William Oh, Emily J. Gallagher, Daning Lu, James O’Kelly, Rajendra G. Mehta and Nils H. Thoennissen and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Amanda Leiter

41 papers receiving 1.4k citations

Hit Papers

The global burden of lung cancer: current status and futu... 2023 2026 2024 2025 2023 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The global burden of lung cancer: current status and future trends
    2023 652 citations Amanda Leiter, Rajwanth Veluswamy et al. Nature Reviews Clinical Oncology profile →

Peers

Amanda Leiter
Yanping Sun China
Shaoyuan Lei China
Weifeng Zhu China
Marcin Czeczelewski Poland
Yue Xi China
Enrique Casado Spain
Steven M. Dubinett United States
Elena Fountzilas Greece
Andrzej Stanisławek Poland
Yanping Sun China
Amanda Leiter
Citations per year, relative to Amanda Leiter Amanda Leiter (= 1×) peers Yanping Sun

Countries citing papers authored by Amanda Leiter

Since Specialization
Citations

This map shows the geographic impact of Amanda Leiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Leiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Leiter more than expected).

Fields of papers citing papers by Amanda Leiter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Leiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Leiter. The network helps show where Amanda Leiter may publish in the future.

Co-authorship network of co-authors of Amanda Leiter

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Leiter. A scholar is included among the top collaborators of Amanda Leiter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Leiter. Amanda Leiter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, A.-B., Grace Mhango, Chung Yin Kong, et al.. (2024). Statin prescription disparities in patients with breast cancer and diabetes for primary cardiovascular disease prevention. Frontiers in Oncology. 14. 1483918–1483918. 2 indexed citations
2.
3.
Leiter, Amanda, Rajwanth Veluswamy, & Juan P. Wisnivesky. (2023). The global burden of lung cancer: current status and future trends. Nature Reviews Clinical Oncology. 20(9). 624–639. 652 indexed citations breakdown →
4.
Leiter, Amanda, Grace Mhango, Chung Yin Kong, et al.. (2023). Impact of diabetes on stage I lung cancer treatment patterns and prognosis in older adults: A population-based cohort study. Heliyon. 9(7). e17969–e17969. 1 indexed citations
5.
Qin, Qian, Tomi Jun, Bo Wang, et al.. (2022). Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysis. Discover Oncology. 13(1). 73–73. 6 indexed citations
6.
Patel, Vaibhav G., Xiaobo Zhong, Himanshu Joshi, et al.. (2022). Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors. Journal of Cancer Research and Clinical Oncology. 149(7). 2833–2841. 15 indexed citations
7.
Sigel, Keith, Chung Yin Kong, Amanda Leiter, et al.. (2022). Assessment of treatment strategies for stage I non-small cell lung cancer in patients with comorbidities. Lung Cancer. 170. 34–40. 8 indexed citations
8.
9.
Leiter, Amanda, Stacyann Bailey, Emily J. Gallagher, et al.. (2021). Assessing the association of diabetes with lung cancer risk. Translational Lung Cancer Research. 10(11). 4200–4208. 19 indexed citations
10.
Leiter, Amanda, et al.. (2020). Management of 3 Cases of Pheochromocytoma During the COVID-19 Pandemic in New York City: Lessons Learned. Journal of the Endocrine Society. 5(2). bvaa198–bvaa198. 5 indexed citations
11.
Sindhu, Kunal K., Amanda Leiter, Eugene Eisenberg, et al.. (2019). Durable Disease Control with Local Treatment for Oligoprogression of Metastatic Solid Tumors Treated with Immune Checkpoint Blockade. International Journal of Radiation Oncology*Biology*Physics. 105(1). E650–E650. 1 indexed citations
12.
Leiter, Amanda, et al.. (2019). Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis. Journal for ImmunoTherapy of Cancer. 7(1). 248–248. 20 indexed citations
13.
Yin, Dong, Seishi Ogawa, Norihiko Kawamata, et al.. (2012). miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme. Oncogene. 32(9). 1155–1163. 95 indexed citations
14.
Yin, Dong, Wangrong Yang, Weikai Chen, et al.. (2012). Cutaneous Papilloma and Squamous Cell Carcinoma Therapy Utilizing Nanosecond Pulsed Electric Fields (nsPEF). PLoS ONE. 7(8). e43891–e43891. 34 indexed citations
15.
Kirschenbaum, Alexander, Xinhua Liu, Yao Shen, Amanda Leiter, & Alice C. Levine. (2011). Prostatic acid phosphatase is expressed in human prostate cancer bone metastases and promotes osteoblast differentiation. Annals of the New York Academy of Sciences. 1237(1). 64–70. 39 indexed citations
16.
Leiter, Amanda. (2009). Whistle . . . And You've Got an Audience. ˜The œFordham urban law journal/Fordham urban law journal. 36(4). 747. 1 indexed citations
17.
Thoennissen, Nils H., James O’Kelly, Daning Lu, et al.. (2009). Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway. Oncogene. 29(2). 285–296. 151 indexed citations
18.
19.
O’Kelly, James, Daning Lu, Amanda Leiter, & H. Phillip Koeffler. (2007). Capsaicin inhibits the growth of breast cancer cells and decreases expression of EGFR and Her2/Neu.. Cancer Research. 67. 5540–5540. 2 indexed citations
20.
Leiter, Amanda. (2001). Environmental Insurance: Does it Defy the Rules. eYLS (Yale Law School). 25(1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanping Sun Breakdown of academic impact, for papers by Shaoyuan Lei Breakdown of academic impact, for papers by Weifeng Zhu Breakdown of academic impact, for papers by Marcin Czeczelewski Breakdown of academic impact, for papers by Yue Xi Breakdown of academic impact, for papers by Enrique Casado Breakdown of academic impact, for papers by Steven M. Dubinett Breakdown of academic impact, for papers by Elena Fountzilas Breakdown of academic impact, for papers by Andrzej Stanisławek
Rankless by CCL
2026